At what level of Thyroid-Stimulating Hormone (TSH) elevation does the risk of atrial fibrillation (afib) increase?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TSH and Atrial Fibrillation Risk: Critical Thresholds

The Question is Backwards: Low TSH, Not High TSH, Precipitates Atrial Fibrillation

Your question asks about elevated TSH causing atrial fibrillation, but the evidence overwhelmingly shows that LOW TSH (indicating hyperthyroidism or overtreatment with levothyroxine) is what precipitates atrial fibrillation, not high TSH. 1

Critical TSH Thresholds for Atrial Fibrillation Risk

TSH <0.1 mIU/L: Highest Risk (Solid Evidence)

  • A 3-fold increased risk of atrial fibrillation occurs over 10 years in patients ≥60 years with TSH ≤0.1 mIU/L, whether from endogenous or exogenous subclinical hyperthyroidism 1
  • A 2.8-fold increased risk of atrial fibrillation develops over just 2 years in patients with TSH <0.1 mIU/L (mean age 65 years) compared to euthyroid controls 1
  • This threshold represents the point where evidence for increased atrial fibrillation risk is "solid" according to expert consensus 1
  • Cardiovascular mortality increases up to 3-fold in individuals >60 years with TSH <0.5 mIU/L 1

TSH 0.1-0.4 mIU/L: Moderate Risk (Limited Evidence)

  • A 5-fold increased risk of atrial fibrillation was found in one study of individuals with TSH <0.4 mIU/L compared to euthyroid individuals ≥45 years 1
  • However, evidence for increased atrial fibrillation risk in the 0.1-0.4 mIU/L range is limited and less consistent 1
  • Some experts believe risk is increased in this range, but the data are not as robust as for TSH <0.1 mIU/L 1

Normal to High TSH: Minimal to No Direct Atrial Fibrillation Risk

  • Subclinical hypothyroidism (elevated TSH with normal free T4) is probably NOT associated with atrial fibrillation 2
  • TSH levels within the normal range or elevated TSH do not significantly increase atrial fibrillation risk 3
  • In euthyroid participants, TSH levels were not significantly associated with incident atrial fibrillation 3

The Real Culprit: High Free T4, Not TSH

In euthyroid individuals with normal TSH, higher free T4 levels are associated with increased atrial fibrillation risk (hazard ratio 1.45 for highest vs lowest quartile), suggesting that thyroid hormone excess—not TSH elevation—drives arrhythmia risk 3, 4

Age as a Critical Modifier

  • The association between low TSH and atrial fibrillation is strongest in patients ≥60-65 years 1
  • Younger patients appear to have lower absolute risk even with suppressed TSH 1

Clinical Implications for Levothyroxine-Treated Patients

  • Approximately 25% of patients on levothyroxine are unintentionally maintained on doses sufficient to fully suppress TSH, significantly increasing atrial fibrillation risk 5
  • Prolonged TSH suppression (<0.1 mIU/L) substantially increases risk for atrial fibrillation and cardiac arrhythmias, especially in elderly patients 5, 6
  • For patients with supraventricular tachycardia and TSH <0.1 mIU/L, treatment is strongly indicated due to solid evidence of increased cardiovascular risk 6

Common Pitfall to Avoid

Do not confuse hypothyroidism (high TSH) with hyperthyroidism (low TSH) when assessing atrial fibrillation risk. The cardiac arrhythmia risk comes from thyroid hormone excess (low TSH), not deficiency (high TSH). 1, 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Treatment for Elevated TSH

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Subclinical Hyperthyroidism with Supraventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.